Latest News

08

November 2017

iX Biopharma Ltd. has reported results for the first financial quarter ended 30 September 2017...

Read On

24

October 2017

iX Biopharma Ltd. delivered a product presentation immediately following the conclusion of the AGM and EGM held on 24 October 2017...

Read On

Our Sublingual Technology

Sublingual wafer administration offers the convenience of use over oral delivery, circumventing the drug breakdown in liver or gastrointestinal tract. The technology also provides rapid absorption, achieving maximum desirable therapeutic effect in a non-invasive manner.

Read On

Contact us

iX Biopharma Ltd

1 Kim Seng Promenade
#14-01 Great World City East Tower
Singapore 237994
T: +65 6235 2270
F: +65 6235 2170
E: info@ixbiopharma.com